4//SEC Filing
Fraser Craig 4
Accession 0001437749-24-023367
CIK 0000946486other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:27 PM ET
Size
8.6 KB
Accession
0001437749-24-023367
Insider Transaction Report
Form 4
Fraser Craig
DirectorPresident and CEO
Transactions
- Award
Warrants (Right to Buy)
2024-07-22+4,011→ 4,011 totalExercise: $4.11→ Common Stock (4,011 underlying) - Award
Series C Preferred Stock
2024-07-22+19→ 19 total→ Common Stock (5,073 underlying)
Footnotes (2)
- [F1]On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value ("Series C Preferred Stock"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the "Purchase Agreement"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date.
- [F2]Pursuant to the Purchase Agreement, the Reporting Person acquired 4,011 warrants to purchase 4,011 shares of the Issuer's common stock, $0.001 par value per share ("Warrants"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the "Initial Exercisability Date"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date.
Documents
Issuer
WINDTREE THERAPEUTICS INC /DE/
CIK 0000946486
Entity typeother
Related Parties
1- filerCIK 0001557420
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 5:27 PM ET
- Size
- 8.6 KB